Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease
Pierre‐Antoine Juge, Keigo Hayashi, Gregory C McDermott, Kathleen M.M. Vanni, Emily Kowalski, Grace Qian, Katarina J Bade, Alene Saavedra, Philippe Dieudé, Paul F. Dellaripa, Tracy J. Doyle, Jeffrey A. Sparks
Topics & Concepts
MedicineInternal medicineTolerabilityPirfenidoneInterstitial lung diseaseNintedanibRheumatoid arthritisCohortRheumatologyVital capacityIdiopathic pulmonary fibrosisRetrospective cohort studyAdverse effectHazard ratioLungConfidence intervalDiffusing capacityLung functionInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisRheumatoid Arthritis Research and TherapiesInflammatory Myopathies and Dermatomyositis